Oncolab
Cheongju
About Oncolab
Oncolab is developing an innovative technology designed to reduce systemic toxicity while enhancing the therapeutic efficacy of cancer treatments. By integrating advanced drug delivery systems, precision targeting mechanisms, and cutting-edge biomedical research, Oncolab aims to improve the safety and effectiveness of oncology therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $684.5K
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: oncolab.co.krko
- Phone: 02-788-7400
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncolab-138110 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.